Characteristics | Categories | Status | Univariate | Multivariate | |||
---|---|---|---|---|---|---|---|
No relapse | Relapse | Hazard ratio | 95% CI | Hazard ratio | 95% CI | ||
Gender | Male | 1654 | 635 | 1.00 | (0.90–1.12) | 0.95 | (0.85–1.06) |
Female | 1648 | 630 | 1.00 (reference) | ||||
Age (years) | 3302 | 1265 | 0.98* | (0.97–0.99) | 0.96* | (0.95–0.98) | |
Geographic location | Metropolitan City | 1727 | 632 | 1.00 (reference) | |||
Province | 1575 | 633 | 1.09 | (0.98–1.22) | 1.02 | (0.92–1.14) | |
Medical benefits | Non-recipient | 3057 | 1187 | 1.00 (reference) | |||
Recipient | 245 | 78 | 0.85 | (0.68–1.07) | 0.85 | (0.68–1.07) | |
Type of medical institution | Tertiary hospital | 543 | 230 | 1.00 (reference) | |||
Community hospital | 846 | 440 | 1.26* | (1.10–1.43) | 1.17* | (1.02–1.33) | |
Clinic | 1321 | 358 | 0.73* | (0.63–0.83) | 0.75* | (0.63–0.90) | |
Antipsychotic drugs | Monotherapy | 1585 | 448 | 1.00 (reference) | |||
Combination therapy | 1442 | 602 | 1.40* | (1.24–1.58) | 1.04 | (0.88–1.21) | |
Other drugs | 275 | 215 | 2.29* | (1.95–2.70) | 2.09* | (1.77–2.46) | |
Medication adherence | 0–50% | 1176 | 660 | 1.60* | (1.42–1.80) | 1.59* | (1.41–1.80) |
50–80% | 452 | 122 | 0.88 | (0.72–1.07) | 0.94 | (0.77–1.15) | |
More than 80% | 1674 | 483 | 1.00 (reference) | ||||
Treatment after initial diagnosis | Outpatient treatment | 2352 | 759 | 1.00 (reference) | |||
Inpatient treatment | 950 | 506 | 1.50* | (1.34–1.67) | 1.46* | (1.24–1.71) |